Trade name: Hiprabovis Balance
Active substance: VPi3 tulpina SF4, VBVD tulpina NADL, VSRB tulpina LYMP 56
Therapeutic group: Organic products
Pharmaceutical form: liofilizat şi solvent pentru suspensie injectabilă
Presentation: flacoane x 10 ml (5, 30 şi 80 doze), 20 ml (5 doze), 100 ml (30 doze), 250 ml (80 doze)
Target species: cattle
Therapeutic action: Bovine Imunoprofilaxia infectiilor cu PI3, BVD, BRS.
Waiting period: 0 zile.
Release mode: Cu prescripţie
Authorization number: 170196
Authorization status: Retrasa
Date of issue of the authorization: 12-09-2017
Authorization valid until: nelimitata
Manufacturer / Serial Release Company: LABORATORIOS HIPRA S.A., Spania
Licensee: LABORATORIOS HIPRA S.A., Spania
Remarks: Autorizatie de comercializare retrasa in data de 13.03.2025, la cererea deținătorului.